Cite
Zhou L, Liu X, Liu H, et al. A comparative study of idarubicin 12 mg/m(2) and 8 mg/m(2) combined with cytarabine as the first induction regimen for adult acute myeloid leukemia patients. Onco Targets Ther. 2016;9:985-91doi: 10.2147/OTT.S96176.
Zhou, L., Liu, X., Liu, H., Zhu, W., Cai, X., Song, K., Zheng, C., Tang, B., & Sun, Z. (2016). A comparative study of idarubicin 12 mg/m(2) and 8 mg/m(2) combined with cytarabine as the first induction regimen for adult acute myeloid leukemia patients. OncoTargets and therapy, 9985-91. https://doi.org/10.2147/OTT.S96176
Zhou, Li, et al. "A comparative study of idarubicin 12 mg/m(2) and 8 mg/m(2) combined with cytarabine as the first induction regimen for adult acute myeloid leukemia patients." OncoTargets and therapy vol. 9 (2016): 985-91. doi: https://doi.org/10.2147/OTT.S96176
Zhou L, Liu X, Liu H, Zhu W, Cai X, Song K, Zheng C, Tang B, Sun Z. A comparative study of idarubicin 12 mg/m(2) and 8 mg/m(2) combined with cytarabine as the first induction regimen for adult acute myeloid leukemia patients. Onco Targets Ther. 2016 Feb 29;9:985-91. doi: 10.2147/OTT.S96176. eCollection 2016. PMID: 27013891; PMCID: PMC4778788.
Copy
Download .nbib